eCFR Reference Browser

---

title: "21 CFR §516.28"

source: "https://www.ecfr.gov/current/title-21/section-516.28"

title_number: "21"

volume_number: "6"

chapter_number: "Unknown"

subchapter_code: "E"

subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"

part_code: "516"

part_subject: "NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES"

subpart_code: "B"

subpart_subject: "Designation of a Minor Use or Minor Species New Animal Drug"

section_number: "516.28"

section_subject: "Publication of MUMS-drug designations."

cfr_reference: "21 CFR 516.28"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 500 to 599"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

FDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Division of Dockets Management, and will contain the following information for each MUMS-designated drug:

(a)The name and address of the sponsor;

(b)The established name and trade name, if any, of the drug;

(c)The dosage form of the drug;

(d)The species and the proposed intended use for which MUMS-drug designation was granted; and

(e)The date designation was granted.

§516.28 - Publication of MUMS-drug designations.